Evidence map›Paper›PMID 35204696›Full record

ReviewBiomolecules2022

Biosynthesis and Biological Significances of LacdiNAc Group on

Kiyoko Hirano, Kiyoshi Furukawa

Abstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Altered Cell SurfaceJournal of proteome research · 2025
    Article
  5. Article
  6. Article
  7. Investigation ofInternational journal of molecular sciences · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. MFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kiyoko HiranoGlycoinformatics Project, The Noguchi Institute, Itabashi, Tokyo 173-0003, Japan.
Kiyoshi FurukawaDepartment of Endocrinology and Diabetes, Medical Center, Saitama Medical University, Kawagoe 350-8550, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of studies have shown that the disaccharide GalNAcβ1→4GlcNAc (LacdiNAc) group bound to

Indexed as

Breast NeoplasmsN-AcetylgalactosaminyltransferasesAnimalsFemaleHumansLactoseMammalsPolysaccharidesLactoseN-acetylgalactosaminyl-1-4-N-acetylglucosamineN-AcetylgalactosaminyltransferasesPolysaccharidesepithelial-mesenchymal or mesenchymal-epithelial transitiongene therapyLacdiNActumor malignancyβ4-N-acetylgalactosaminyltransferase

Identifiers

PMID35204696
PMCPMC8961560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.